Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
about
Natural Phytochemicals in the Treatment and Prevention of Dementia: An OverviewWeight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analysesDrugs, games, and devices for enhancing cognition: implications for work and society.Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review.The Diagnosis of Delirium Superimposed on Dementia: An Emerging ChallengeLewy Body Disorders.Acute movement disorders in the medical setting.New Therapeutic Strategies for Lewy Body Dementias.Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates.Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.Non-pharmacological interventions for Lewy body dementia: a systematic review.Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives.Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias.Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia.Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Clinical Practice Guidelines for Management of Dementia.Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia
P2860
Q26750581-20E71F87-CB9C-411B-B3AE-98D9584E108AQ30234535-C2B58364-ECEC-4B58-B55C-FC16826E5219Q31155412-FD50B37B-52E1-4298-B8D0-AEA000BC9293Q33869820-8EFA73BA-FB2F-4242-82AD-8A442E4DEA1CQ37196381-B91D1A2C-60EC-4E05-BC74-AF0A14EE88D6Q38797653-FF36713C-C3D4-4FC5-9AD3-A5D907702920Q38801245-EC119E1B-AF87-4834-8CFB-8CF79E0EB44CQ38810415-00DB1B0D-C92C-4139-B6E1-A321DD77AD19Q39243369-640BF725-EE2B-4F44-8AE3-F615B4CBB971Q39383551-FA41CCBD-6F9B-433F-B721-6E4317B22302Q39456457-EEF9E7F6-2386-4EFC-AC14-93A705E3B1AFQ41256308-DA5FB64B-929A-401C-8D1E-899A01B0DBBAQ47231236-51F2E14E-294B-4019-AC88-7086A5368DACQ47587666-E0E0701E-8F39-4C03-AF1C-129633702768Q47673497-7D3D1881-7E1E-459E-BC22-2DA150B4D5FEQ47923287-A2107CA5-BE29-472A-A676-8B5EA3C88256Q48028680-1D3CC445-00B3-4D1D-AA4B-BE68E62DC838Q49901259-5B41C22A-228C-4FDB-9820-0AB0693B0E2AQ49987358-2E1158A2-1B4D-43F7-91D0-4D0AD4D8F942Q51583546-D27667EB-7886-4244-B06C-D3B6F57CA140Q54982491-AFF7BF96-0C9E-4047-8A83-EC6117F27207Q55037013-DAA75A4C-6950-4D87-B203-844820F9C651Q58791278-1FC596A3-F73B-452A-86FE-35700491823A
P2860
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
@en
type
label
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
@en
prefLabel
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
@en
P2093
P50
P1476
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis
@en
P2093
Alan Thomas
Elijah Mak
Victoria Cambridge
P304
P356
10.1176/APPI.AJP.2015.14121582
P407
P50
P577
2015-06-18T00:00:00Z